Reuters logo
BRIEF-Redhill Biopharma announces last patient visit in Bekinda phase II study for IBS-D
July 17, 2017 / 12:25 PM / 2 months ago

BRIEF-Redhill Biopharma announces last patient visit in Bekinda phase II study for IBS-D

July 17 (Reuters) - Redhill Biopharma Ltd:

* Redhill Biopharma announces last patient visit in Bekinda phase II study for IBS-D

* Redhill Biopharma Ltd- ‍top-line results are expected in September 2017 from study​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below